(1.BETA.,10.ALPHA.,11.BETA.,16.BETA.)-21-(ACETYLOXY)-1,11-EPOXY-2'-METHYL-5'H-PREGN-4-ENO(17,16-D)OXAZOLE-2,20-DIONE

UNII:	NZJ93E7B2F
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₃₁NO₆
Preferred Substance Name:	(1.BETA.,10.ALPHA.,11.BETA.,16.BETA.)-21-(ACETYLOXY)-1,11-EPOXY-2'-METHYL-5'H-PREGN-4-ENO(17,16-D)OXAZOLE-2,20-DIONE
InChIKey:	BHWRJQMIVPLQQH-ZFSDNTCOSA-N
GSRS Full Record:	NZJ93E7B2F i

2071691-88-6
(1β,10α,11β,16β)-21-(Acetyloxy)-1,11-epoxy-2′-methyl-5′H-pregn-4-eno[17,16-d]oxazole-2,20-dione
5′H-Pregn-4-eno[17,16-d]oxazole-2,20-dione, 21-(acetyloxy)-1,11-epoxy-2′-methyl-, (1β,10α,11β,16β)-

Common Chemistry
i
Inxight Drugs
i
PubChem
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

(1.BETA.,10.ALPHA.,11.BETA.,16.BETA.)-21-(ACETYLOXY)-1,11-EPOXY-2'-METHYL-5'H-PREGN-4-ENO(17,16-D)OXAZOLE-2,20-DIONE

Synonyms and Mappings

Resources